Aveo Capital Partners’s CME Group CME Stock Holding History

Aveo Capital Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,096	Closed	-$228K	–	324
2024 Q1	$228K	Buy	1,096 +22	+2%	+$4.62K	0.02%	331
2023 Q4	$226K	Buy	+1,074	New	+$229K	0.03%	308

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Aveo Capital Partners's CME Position: Q2 2024 in Review

Aveo Capital Partners sold out of CME Group (CME) in Q2 2024, closing a stake of 1,096 shares — an estimated $228K sold.

Aveo Capital Partners first reported a position in CME in Q4 2023 and held it in 2 quarters. The position peaked at $228K in Q1 2024. 1,377 funds tracked by Wall St. Rank hold CME as of Q2 2024.

Aveo Capital Partners reported no remaining CME Group position as of Q2 2024 after selling out during the quarter.
Aveo Capital Partners sold 1,096 CME Group shares in Q2 2024, an estimated $228K.
Aveo Capital Partners first reported a position in CME Group in Q4 2023 and held it in 2 quarters.
Aveo Capital Partners's CME Group position peaked at $228K in Q1 2024.
1,377 funds tracked by Wall St. Rank held CME Group as of Q2 2024.

Based on Aveo Capital Partners's 13F filing for Q2 2024, filed 2 Aug 2024.